article thumbnail

What are the most valuable recommendations in order to raise money from VCs connected via Gust?

Gust

Because Gust is the word’s most comprehensive database of high-growth startup companies (in terms of size, larger than Crunchbase and AngelList combined), it is increasingly used as a source for third party listings and directories. This added exposure can result in indications of interest (investment, acquisition, partnership, etc.)

article thumbnail

Gazzang Banks $3.5M Series A

Austin Startup

Austin Ventures was the lead institutional investor, accompanied by a group of smaller individual investors. In addition, software industry veteran Larry Warnock, who led the acquisition of Phurnace Software by BMC Software earlier this year, has joined Gazzang as CEO. Gazzang, Inc.,

SQL 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

VCs eating our own dog food: Using technology and analytics to make better investments

David Teten

I use another live Google doc to maintain my database of companies I’m marketing to other VCs. That Google document provides cut and pasteable text I can share with other investors, based on their stage, focus, and appetite. . I’ve used Asana extensively to manage activities firm-wide. Deer Isle Group has built the D.I.G.

article thumbnail

10 Tools for Understanding and Dissecting an Industry

VC Cafe

GLG continued to build it’s expert consulting network in the years to follow to become one of the top primary research tools for institutional investors because they have helped their customers to make things simple quickly. Simple can be harder than complex: You have to work hard to get your thinking clean to make it simple.

Curation 167
article thumbnail

Reinventing Life Science Startups–Therapeutics and Diagnostics

Steve Blank

For exits, acquisitions are the rule and IPOs the exception. It has gotten so bad that pension funds and other institutional investors in venture capital funds have told these funds to stay away from Life Science – or at the least, early stage Life Science. WTF is going on? — which have sped up their search dramatically.